Bioniz
Biotechnology company focused on discovering small peptides and molecules for the treatment of autoimmune diseases and cancer. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$329m (Public information from Feb 2022)
California United States (HQ)
Authorizing premium user...